Latest KLDO reports update at 2023-12-23: 20212020
Kaleido Biosciences logo
Kaleido Biosciences KLDO
$ 0.29 -3.69%

Kaleido Biosciences Financial Statements 2011-2024 | KLDO

Annual Financial Statements Kaleido Biosciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

73.7 M 538 M 221 M - - - - - - - -

Shares

41.9 M 36 M 25.7 M - - - - - - - -

Historical Prices

1.76 14.9 8.58 - - - - - - - -

Net Income

-90.3 M -81.6 M -86.3 M -61.7 M -27.6 M -9.68 M - - - - -

Revenue

1.1 M 975 K - - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 975 K - - - - - - - - -

Operating Income

-87.7 M -78.9 M -86.7 M -60.7 M - - - - - - -

Interest Expense

2.84 M 2.8 M 977 K 1 M - - - - - - -

EBITDA

-85.3 M -77.1 M -85.4 M -59.9 M -26.7 M -9.34 M - - - - -

Operating Expenses

88.8 M 79.8 M 86.7 M - - - - - - - -

General and Administrative Expenses

21 M 23.9 M 22.4 M 18.6 M 6.04 M 1.57 M - - - - -

All numbers in USD currency

Quarterly Income Statement Kaleido Biosciences

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - 42.6 M 42.6 M 42.5 M 39.7 M 36 M 35.6 M 31.9 M 30.3 M 30.1 M 29.9 M 29.7 M 13 M 5.79 M 5.15 M 4.81 M 4.74 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - -23.1 M -23.9 M -23 M - -23.1 M -18.9 M -19.6 M - -22 M -24.6 M -20.2 M - -17.4 M -12.3 M -10.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - 104 K 211 K 297 K - 482 K 250 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - -22.4 M -23.2 M -22.3 M - -22.4 M -18.1 M -19.1 M - -22.1 M -25 M -20.6 M - -17.3 M -12.4 M -10.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - 709 K 705 K 709 K - 713 K 683 K 688 K - 258 K 260 K 258 K - 243 K 253 K 249 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - -21.8 M -22.6 M -21.8 M - -21.9 M -17.8 M -18.7 M - -21.8 M -24.6 M -20.3 M - -17.1 M -12.2 M -10.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - 22.5 M 23.4 M 22.6 M - 22.9 M 18.4 M 19.1 M - 22.1 M 25 M 20.6 M - 17.3 M 12.4 M 10.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - 5.11 M 5.78 M 5.46 M - 7.2 M 5.56 M 5.92 M - 5.93 M 6.18 M 5.43 M - 7.14 M 3.21 M 2.67 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency